TY - JOUR T1 - Re-treatment after laser in situ keratomileusis for correction of myopia and myopic astigmatism JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 1506 LP - 1510 DO - 10.1136/bjo.2008.143636 VL - 92 IS - 11 AU - M A Bragheeth AU - U Fares AU - H S Dua Y1 - 2008/11/01 UR - http://bjo.bmj.com/content/92/11/1506.abstract N2 - Aim: To evaluate the results of laser in situ keratomileusis (LASIK) re-treatment for under correction or regression after primary LASIK procedures for myopia and myopic astigmatism.Methods: A prospective evaluation of 360 consecutive LASIK-treated eyes, for myopia and/or myopic astigmatism, 32 eyes of 34 patients were retreated and followed at 3, 6 and 12 months post-retreatment. Re-treatment was performed by lifting the original flap after cutting the epithelium around the flap edge with a fine needle. Standard ablation was performed based on the patient’s residual refraction.Results: 9.4% of eyes required retreatment. Prior to re-treatment the mean manifest spherical equivalent (SE) was −0.99 (SD 1.48) D (range −0.75 to −2.63). The mean sphere was −0.79 (1.20) D (range −2.50 to −0.50), and the mean cylinder was −0.90 D (1.14) D (from −2.75 to 1.25). At 1-year follow-up 56% of the eyes were within ±0.50 D SE, and 78% were within ±1.00 D SE. 78% of the eyes examined at 1-year post-re-treatment managed unaided vision of 6/9 or better. Peripheral epithelial ingrowth not requiring treatment developed in two eyes. Second re-treatment for regression was performed in one eye. A significant correlation was found between the refractive regression and each of the following: preoperative refraction, attempted correction and ablation depth.Conclusion: LASIK re-treatment for residual myopia, by lifting the original flap, is an effective option. Refractive results are fairly predictable, and refraction stabilises by 3 months after re-treatment. Lifting the corneal flap after cutting the epithelium on the flap edges is easy to perform and has a very low incidence of epithelial ingrowth. ER -